Radioprotective Effect of Caffeic Acid Phenethyl Ester on the Brain Tissue in Rats Who Underwent Total-Head Irradiation

Basit öğe kaydını göster

dc.contributor.author Khayyo, Nesrin
dc.contributor.author Ulusal, Hasan
dc.contributor.author Tarakçıoğlu, Mehmet
dc.contributor.author Taysı, Seyithan
dc.contributor.author Taysı, Muhammed Enes
dc.contributor.author Demir, Elif
dc.contributor.author Çınar, Kadir
dc.date.accessioned 2021-12-15T12:08:44Z
dc.date.available 2021-12-15T12:08:44Z
dc.date.issued 2019
dc.identifier.issn 2564-7784
dc.identifier.issn 2564-7040
dc.identifier.uri http://openaccess.sanko.edu.tr/xmlui/handle/20.500.12527/605
dc.description.abstract Objective: In this study, we evaluated whether caffeic acid phenethyl ester (CAPE) has a radioprotective effect on the damage in the rat brain tissue induced by gamma radiation, considering that it may inhibit the ionizing radiation damage.Methods: A total of 36 Sprague–Dawley rats were divided into four groups to test the radioprotective effect of CAPE administered by intraperitoneal injection. An appropriate control group was also studied. On day 11, the brain tissue of all rats was removed and homogenized in phosphate buffer, and the total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), paraoxonase (PON), arylesterase (ARE), ceruloplasmin (CER), lipid hydroperoxide (LOOH), and total-SH parameters were measured to determine if CAPE had a protective effect.Results: The ARE and PON activity and the total-SH level were statistically increased compared to the IR group, whereas the LOOH, TOS, and OSI levels were significantly decreased.Conclusion: The data obtained in the study suggest that the CAPE administration prior to irradiation may prevent the irradiation brain damage. en_US
dc.language.iso English en_US
dc.publisher AVES Yayıncılık en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title Radioprotective Effect of Caffeic Acid Phenethyl Ester on the Brain Tissue in Rats Who Underwent Total-Head Irradiation en_US
dc.type Article en_US
dc.relation.journal European Journal of Therapeutics en_US
dc.identifier.issue 4 en_US
dc.identifier.startpage 265 en_US
dc.identifier.endpage 272 en_US
dc.identifier.volume 25 en_US
dc.contributor.authorID 0000-0002-4517-3808 : Kadir Çınar en_US
dc.identifier.doi https://doi.org/10.5152/EurJTher.2019.18052 en_US
dc.contributor.sankoauthor Kadir Çınar en_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

Gazimuhtar Paşa Bulvarı
No:36
27090
Şehitkamil / GAZİANTEP